相关实验视频
Updated: May 10, 2025
09:16
Assessment of Kidney Function in Mouse Models of Glomerular Disease
Published on: June 30, 2018
17.4K
在使用SGLT2抑制剂后影响早期功能变化的因素及其长期预后:现实世界的回顾性研究
Bing Xie1, Nan Ye1, Guoqin Wang1
1Division of Nephrology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Renal failure
|April 28, 2025
概括
-葡萄糖共运输体2抑制剂 (SGLT2i) 可以导致血清肌素短期上升,但不会显著影响长期功能. 较低的基线eGFR和血清白蛋白是这种短暂变化的危险因素.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 药理学 药理学是指药理学的学科.
- 内部医学 内部医学
背景情况:
- -葡萄糖共运输体2抑制剂 (SGLT2i) 以其对的保护作用而闻名.
- 在SGLT2i的潜在副作用是SGLT2i开始后不久,血清肌素水平的短暂上升.
- 了解影响这种变化的因素及其长期脏影响至关重要.
研究的目的:
- 在开始SGLT2i治疗的患者中调查与短期血清肌素增加相关的因素.
- 为了评估经历这种短暂变化的患者的长期功能结果.
主要方法:
- 对544名开始SGLT2i的患者进行了回顾性研究.
- 根据3个月的血清肌素变化,患者被分为功能恶化 (RD) 和非功能恶化 (non-RD) 组.
- 多变量逻辑回归和混合效应线性模型用于分析影响因素和eGFR斜率.
主要成果:
- 14.3%的患者经历了RD. 较低的eGFR和血清白蛋白是RD的独立风险因素.
- 在eGFR的10mL/min/1.73m2下降增加了42.3%的RD风险;在血清白蛋白的5g/L下降增加了41.7%的风险.
- 在短期内观察到eGFR和eGFR斜率的显著差异,但不是长期 (3年).
结论:
- 随着SGLT2i启动,血清肌素 (和相关的RD) 的短暂增加与较低的基线eGFR和血清白蛋白有关.
- 尽管SGLT2i治疗的短期波动,但SGLT2i治疗并没有导致小组之间的功能长期显著差异.
更多相关视频
相关概念视频
01:17Factors Affecting Renal Clearance: Renal Impairment
30
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
30
01:11Renal Failure: Dose Adjustments
34
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
34
01:27Glucose Transporters
22.2K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.2K
01:23Dipeptidyl Peptidase 4 Inhibitors
117
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
117
01:31Factors Affecting Renal Clearance: Drug's Physicochemical Properties and Plasma Levels
121
Renal clearance of a drug is influenced by various factors, including its physicochemical properties and plasma levels. These factors play a significant role in determining how efficiently the kidneys eliminate a drug.
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
121
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
133
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
133